Tag:
Acute Lymphoblastic Leukemia
Latest Headlines
Latest Headlines
FDA to rule soon on Tekmira-created nanoparticle chemo drug
May 13 is the do-or-die date for Marqibo, a nanoparticle-delivered injectable cancer drug conceived by Canada's Tekmira Pharamceuticals ( $TKMR ).
Immunomedics promotes 2 cancer treatments to later-stage trials
Immunomedics ($IMMU) has generated mostly promising data from two new lymphoma treatments that use the company's "Dock-and-Lock" targeted drug delivery technology. The company describes the DNL tech,
